2-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-1H-imidazole-4-carboxylic acid

Catalog No. :
ACYMPM900
CAS No. :
2172537-48-1
Molecular Formula :
C24H23N3O4
Molecular Weight :
417.46

IUPAC Name:2-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-1H-imidazole-4-carboxylic acid

2-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-1H-imidazole-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-1H-imidazole-4-carboxylic acid
IUPAC Name2-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)-1H-imidazole-4-carboxylic acid
Molecular FormulaC24H23N3O4
Molecular Weight417.46
SMILESO=C(O)C1=CNC(C2CCN(C(=O)OCC3C4=CC=CC=C4C4=CC=CC=C43)CC2)=N1
InChI KeyQZJMQAPRISNIEJ-UHFFFAOYSA-N
Synonym2-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-1H-imidazole-4-carboxylic acid;1-Piperidinecarboxylic acid, 4-(5-carboxy-1H-imidazol-2-yl)-, 1-(9H-fluoren-9-ylmethyl) ester
CAS No.2172537-48-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYMPM900 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYMPM900 route product structure diagram
    ACYMPM9002172537-48-1
Inquiry

2. ACYMPM900 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYMPM900 route product structure diagram
    ACYMPM9002172537-48-1
Inquiry

Comments (0)